-
-
-
-
-
-
-
Vertex and CRISPR Therapeutics Announce US FDA Approval of CASGEVYâ„¢
-
-
-
-
-
-
-
CRISPR Therapeutics (CRSP) Announces Completion of FDA AdCom for exa-cel for Severe Sickle Cell Disease
-
-
-
-
-
-
-
Vertex Pharma (VRTX) Reports Positive Results From Pivotal Trials of exa-cel for Transfusion-Dependent Beta Thalassemia and Severe Sickle Cell Disease
-
-
-
-
-
-
14,982 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

